HOOKIPA Pharma Revenue

Biotechnology Research • Manhattan, New York, United States • 21-50 Employees

HOOKIPA Pharma revenue & valuation

Annual revenue	$9,351,000
Revenue per employee	$218,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$30,000,000
Total funding	$64,400,000

Key Contacts at HOOKIPA Pharma

Malte Peters

Chief Executive Officer

Kerstin Rumpelmayr

Senior Director - Chemistry, Manufacturing And Control Launch Readiness

Rashmi Tuladhar

Director, Clinical Biomarker Operations

Silvia Schneider

Executive Director – Cost Accounting & Controlling

Susan Trinker

Executive Director, Commercial Strategy

Sandya Moussa

Executive Director - Finance

Alexander Grill

Director Of Regulatory Affairs

Melanie Spiess

Manager Qa - Product Owner & Document Management

Company overview

Headquarters	The Empire State Building, 350 Fifth Avenue, Room/Suite 7240, New York, New York NY 10118 , US
Phone number	+4318906360
Websites	hookipapharma.com hookipabiotech.com
NAICS	541714
SIC	873
Keywords	Immunotherapy, Infectious Diseases, Immuno-Oncology
Founded	2011
Employees	21-50
Socials

HOOKIPA Pharma Email Formats

HOOKIPA Pharma uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@hookipapharma.com), used 48.8% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@hookipapharma.com	48.8%
{first initial}.{last name}	j.doe@hookipapharma.com	43.9%
{first initial}{last name}	jdoe@hookipapharma.com	7.3%

About HOOKIPA Pharma

At HOOKIPA, we envision a world in which cancers and infectious diseases can be chronically managed or eradicated. HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company advancing the field of immunotherapy through the development of new immunotherapies based on our proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. Our pipeline includes wholly owned investigational arenaviral immunotherapies targeting HPV16+ cancers, prostate cancer, KRAS-mutated cancers (including colorectal, pancreatic and lung), and other undisclosed programs. In addition, HOOKIPA aims to develop functional cures for HBV and HIV in collaboration with Gilead. As a company, we fight for innovation; we challenge ourselves to act authentically and transparently; we thrive on our differences; and we go for it, never giving up in our efforts to eliminate the suffering of people with cancer and infectious disease. To learn more please visit www.hookipapharma.com.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Manager

Senior

Director

Employees by Department

HOOKIPA Pharma has 24 employees across 11 departments.

Departments

Number of employees

Funding Data

Explore HOOKIPA Pharma's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-07-01	14	$50,000,000
2024-01-21	14	$14,400,000

Funding Insights

$64,400,000

Total funding amount

$14,400,000

Most recent funding amount

Number of funding rounds

HOOKIPA Pharma Tech Stack

Discover the technologies and tools that power HOOKIPA Pharma's digital infrastructure, from frameworks to analytics platforms.

Thawte

SSL/TLS certificate authorities

Apache HTTP Server

Web servers

Apple iCloud Mail

Webmail

PHP

Programming languages

Open Graph

Miscellaneous

TYPO3 CMS

CMS

PWA

Miscellaneous

Google Maps

Maps

Microsoft 365

Frequently asked questions

HOOKIPA Pharma is located in Manhattan, New York, US.

You can reach HOOKIPA Pharma at +4318906360.

HOOKIPA Pharma generates an estimated annual revenue of $9,351,000. This revenue figure reflects the company's market position and business performance in its industry.

HOOKIPA Pharma has an estimated valuation of $30,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

HOOKIPA Pharma was founded in 2011, making it 15 years old. The company has established itself as a significant player in its industry over this time.

HOOKIPA Pharma has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

HOOKIPA Pharma has raised a total of $64,400,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.